On June 14, 2007, Mark Waxman presented at an AdvaMed MTLI Audio Conference on “CME Programs – Guidelines and Pitfalls for Sponsorship and Support.”
Topics discussed included the following:
- Why sponsor CME programs? What are the benefits to providers and to sponsors?
- What is the dividing line between education and promotion?
- What are the differences between formal CME programs and non-physician continuing education programs with manufacturer involvement?
- What are the risks of off-label promotion?
- What control does a sponsor have over CME program content?
- How does one draft the most equitable and productive Letter of Agreement between industry sponsors and CME providers?
- How can companies reduce their exposure to regulatory concerns?
Speakers:
- Sandy C. Kalter, Senior Legal Director and FDA Counsel, Corporate Legal/Regulatory, Medtronic, Inc.
- Sue Seferian, Senior Counsel, Johnson & Johnson
- Mark Waxman, Partner, Foley & Lardner LLP
Related Insights
August 15, 2025
Health Care Law Today
DOJ Consumer Branch's End Leaves FDA Litigation Questions
With the dissolution of the U.S. Department of Justice's Consumer Protection Branch set to occur by Sept. 30, a vital question that…
August 14, 2025
Foley Ignite
Will the Late Summer M&A Rebound Continue into Fall?
The lazy days of summer seem to be behind us as merger and acquisition (M&A) activity is getting a jump start. A recent article in the…
August 14, 2025
Manufacturing Industry Advisor
Tariffs and Your Contracts: Why do delivery terms matter?
In light of a trade landscape rife with tariffs, companies are examining their commercial contracts to judge the exposure to increased costs of production. One area of a supply contract that cannot be overlooked when determining this type of exposure is the delivery terms for the product sale. This is because the delivery terms of a contract may identify the party responsible for payment of tariffs.